CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-11-11 12:14 Tx date 2024-11-08	$VPH VALEO PHARMA INC.	Dumais, Frédéric 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		40,000
Filed 2024-11-11 12:13 Tx date 2024-11-08	$VPH VALEO PHARMA INC.	Dumais, Frédéric 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report		$45,000
Filed 2024-11-11 12:12 Tx date 2024-11-08	$VPH VALEO PHARMA INC.	Dumais, Frédéric 5 - Senior Officer of Issuer Holder: 9393-0907 Quebec Inc (Indirect Ownership)	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		41,000
Filed 2024-11-11 12:11 Tx date 2024-11-08	$VPH VALEO PHARMA INC.	Dumais, Frédéric 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		217,500
Filed 2024-04-30 11:55 Tx date 2024-02-19	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-222,222 vol	225,000
Filed 2024-03-25 09:26 Tx date 2024-03-21	$VPH VALEO PHARMA INC.	Moghaddam, Ali Ghaderi 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2024-02-14 15:10 Tx date 2024-02-14	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	$2,271 +8,572 vol $0.265 each	21,965
Filed 2024-02-14 15:08 Tx date 2024-02-14	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	$-3,549.145 -13,393 vol $0.265 each	0
Filed 2024-02-13 17:20 Tx date 2024-02-12	$VPH VALEO PHARMA INC.	Bisaillon, Charles 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-11-29 13:01 Tx date 2023-11-29	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	+13,393 vol	13,393
Filed 2023-11-29 13:00 Tx date 2023-11-29	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-13,393 vol	13,393
Filed 2023-11-29 12:57 Tx date 2023-11-29	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	+19,394 vol	19,394
Filed 2023-11-29 12:56 Tx date 2022-08-29	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-11-29 12:56 Tx date 2023-11-29	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-30,303 vol	0
Filed 2023-11-22 09:50 Tx date 2023-11-20	$VPH VALEO PHARMA INC.	Tougas, Pascal 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+300,000 vol	300,000
Filed 2023-11-22 09:48 Tx date 2023-11-20	$VPH VALEO PHARMA INC.	Tougas, Pascal 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-11-22 09:47 Tx date 2023-11-20	$VPH VALEO PHARMA INC.	Tougas, Pascal 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-11-09 12:22 Tx date 2023-11-01	$VPH VALEO PHARMA INC.	Lajoie, Richard 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-28 17:53 Tx date 2023-09-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 38 - Redemption, retraction, cancellation, repurchase	+650,000 vol	23,322,987
Filed 2023-09-28 10:40 Tx date 2023-09-25	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 38 - Redemption, retraction, cancellation, repurchase	+650,000 vol	2,648,055
Filed 2023-09-26 13:50 Tx date 2023-09-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 38 - Redemption, retraction, cancellation, repurchase	+650,000 vol	25,372,987
Filed 2023-09-25 13:24 Tx date 2023-09-20	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Simcor Canada Holdings Inc. (Control or Direction)	Common Shares Class A 11 - Acquisition or disposition carried out privately	$-130,000 -520,000 vol $0.25 each	3,694,145
Filed 2023-09-25 13:12 Tx date 2023-09-20	$VPH VALEO PHARMA INC.	Simcor Canada Holdings Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 11 - Acquisition or disposition carried out privately	$-130,000 -520,000 vol $0.25 each	1,694,145
Filed 2023-09-18 11:00 Tx date 2023-09-13	$VPH VALEO PHARMA INC.	Ecclestone, Pierre Leslie Conrad 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+180,000 vol	180,000
Filed 2023-09-18 10:59 Tx date 2023-08-08	$VPH VALEO PHARMA INC.	Ecclestone, Pierre Leslie Conrad 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-14 17:57 Tx date 2023-09-13	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$22,750 +65,000 vol $0.35 each	1,477,500
Filed 2023-09-11 16:28 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants (31AUG2028, $0.35) 16 - Acquisition or disposition under a prospectus exemption	$156,249 +446,428 vol $0.35 each	446,428
Filed 2023-09-11 16:27 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-11 16:25 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$249,999 +892,857 vol $0.28 each	22,672,987
Filed 2023-09-06 13:59 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-25,500 vol	0
Filed 2023-09-01 12:55 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Investissement Québec 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report		$10,000,000
Filed 2023-09-01 12:54 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Investissement Québec 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report		3,571,429
Filed 2023-09-01 12:54 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Investissement Québec 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		7,142,857
Filed 2023-09-01 12:31 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 16 - Acquisition or disposition under a prospectus exemption	$156,249 +446,428 vol $0.35 each	446,428
Filed 2023-09-01 12:28 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-01 12:27 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$232,142 +892,857 vol $0.26 each	24,722,987
Filed 2023-09-01 11:54 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$1,169,999 +4,178,571 vol $0.28 each	16,176,455
Filed 2023-09-01 11:54 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants (31AUG2028, $0.35) 16 - Acquisition or disposition under a prospectus exemption	$731,249 +2,089,285 vol $0.35 each	2,089,285
Filed 2023-09-01 11:53 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-01 11:52 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 16 - Acquisition or disposition under a prospectus exemption	$731,249 +2,089,285 vol $0.35 each	2,089,285
Filed 2023-09-01 11:51 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-01 11:51 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$1,169,999 +4,178,571 vol $0.28 each	16,176,455
Filed 2023-09-01 11:48 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 16 - Acquisition or disposition under a prospectus exemption	$624.75 +1,785 vol $0.35 each	1,785
Filed 2023-09-01 11:47 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants (31AUG2028, $0.35) 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-01 11:41 Tx date 2023-08-31	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$999.88 +3,571 vol $0.28 each	393,571
Filed 2023-08-30 13:46 Tx date 2022-12-21	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	$23,250 +50,000 vol $0.465 each	1,358,369
Filed 2022-12-21 13:53 Tx date 2022-12-21	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	$2,500,000,000 +50,000 vol $50,000 each
Filed 2023-08-28 14:08 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-200,000 vol	0
Filed 2023-08-28 13:44 Tx date 2023-04-26	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 55 - Expiration of warrants	-40,000 vol	0
Filed 2023-08-28 13:42 Tx date 2023-04-26	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 55 - Expiration of warrants	-400,000 vol	0
Filed 2023-08-18 15:45 Tx date 2023-08-18	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$32,000 +100,000 vol $0.32 each	1,998,055
Filed 2023-07-26 15:35 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$100,000 +100,000 vol $1.00 each	8,254,965
Filed 2023-07-26 15:34 Tx date 2022-03-04	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 36 - Conversion or exchange	$1,367 +3,419 vol $0.40 each	11,367,384
Filed 2023-07-26 15:33 Tx date 2022-03-04	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 36 - Conversion or exchange	$1,040,000 +2,600,000 vol $0.40 each	11,363,965
Filed 2023-05-01 13:27 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Fowler, Stuart William 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 11:10 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-27,778 vol	0
Filed 2023-05-01 10:40 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	+37,037 vol	641,972
Filed 2023-05-01 10:40 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-37,037 vol	0
Filed 2023-05-01 10:37 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	+27,778 vol	2,331,414
Filed 2023-05-01 10:36 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		2,303,636
Filed 2023-05-01 10:34 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-27,778 vol	0
Filed 2023-05-01 10:32 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	+27,778 vol	27,778
Filed 2023-05-01 10:31 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 10:31 Tx date 2023-03-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-27,778 vol	0
Filed 2023-05-01 10:31 Tx date 2023-03-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-27,778 vol
Filed 2023-05-01 10:28 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Common Shares Class A 57 - Exercise of rights	+46,296 vol	46,296
Filed 2023-05-01 10:27 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 10:27 Tx date 2023-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-46,296 vol	0
Filed 2023-03-22 18:40 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$264,000 +400,000 vol $0.66 each	550,000
Filed 2023-03-17 12:05 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$198,000 +300,000 vol $0.66 each	1,412,500
Filed 2023-03-17 10:16 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$66,000 +100,000 vol $0.66 each	275,000
Filed 2023-03-17 10:14 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$66,000 +100,000 vol $0.66 each	447,222
Filed 2023-03-17 10:12 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$66,000 +100,000 vol $0.66 each	225,000
Filed 2023-03-17 10:10 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$99,000 +150,000 vol $0.66 each	650,000
Filed 2023-03-17 10:07 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$66,000 +100,000 vol $0.66 each	300,000
Filed 2023-03-17 10:04 Tx date 2023-03-15	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$99,000 +150,000 vol $0.66 each
Filed 2023-02-27 14:28 Tx date 2023-02-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$105,966 +264,917 vol $0.40 each	517,323
Filed 2023-02-27 14:26 Tx date 2023-02-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 36 - Conversion or exchange	$ -$100,000 vol $0.40 each	$0
Filed 2023-02-07 15:34 Tx date 2023-02-02	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	+404,935 vol	604,935
Filed 2023-02-07 15:32 Tx date 2023-02-07	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 36 - Conversion or exchange	$ -$154,000 vol $0.40 each	$0
Filed 2023-01-31 15:02 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$16,800 +30,000 vol $0.56 each	30,000
Filed 2023-01-31 15:01 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-31 13:27 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$54,000 +96,429 vol $0.56 each	96,429
Filed 2023-01-31 13:25 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-31 07:22 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$100,000 +178,572 vol $0.56 each	178,572
Filed 2023-01-31 07:19 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-29 10:51 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$15,000 +26,786 vol $0.56 each	26,786
Filed 2023-01-29 10:49 Tx date 2021-06-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-29 10:46 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$17,500 +31,250 vol $0.56 each	31,250
Filed 2023-01-29 10:44 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-29 10:41 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$12,375 +22,099 vol $0.56 each	22,099
Filed 2023-01-29 10:41 Tx date 2023-01-27	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 56 - Grant of rights	$21,000 +37,500 vol $0.56 each	37,500
Filed 2023-01-29 10:39 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-29 10:39 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-12-21 13:53 Tx date 2022-12-21	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	$2,500,000,000 +50,000 vol $50,000 each	1,358,369
Filed 2022-12-21 13:52 Tx date 2022-12-21	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	-50,000 vol	0
Filed 2022-11-25 10:47 Tx date 2022-11-25	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 57 - Exercise of rights	$13,250 +25,000 vol $0.53 each	1,402,150
Filed 2022-11-25 10:45 Tx date 2022-11-25	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 57 - Exercise of rights	$-13,250 -25,000 vol $0.53 each	0
Filed 2022-11-23 15:51 Tx date 2022-11-21	$VPH VALEO PHARMA INC.	Fasano, Frederic 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-2,050,000 vol	0
Filed 2022-10-07 16:55 Tx date 2022-10-05	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$5,200 +10,000 vol $0.52 each	180,745
Filed 2022-09-29 14:51 Tx date 2022-09-22	$VPH VALEO PHARMA INC.	Simcor Canada Holdings Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 11 - Acquisition or disposition carried out privately	$-1,160,000 -2,000,000 vol $0.58 each	2,214,145
Filed 2022-09-29 12:59 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Klug Investments Inc (Indirect Ownership)	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-32,909 vol	0
Filed 2022-09-29 12:52 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-58,428 vol	0
Filed 2022-09-29 12:25 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-360,515 vol	25,500
Filed 2022-09-29 12:06 Tx date 2022-09-22	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 11 - Acquisition or disposition carried out privately	$1,160,000 +2,000,000 vol $0.58 each	23,830,130
Filed 2022-09-26 11:21 Tx date 2022-07-10	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-75,000 vol	200,000
Filed 2022-09-26 10:31 Tx date 2022-09-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants VPH.WT. A.(10SEP2022 Warrants) 55 - Expiration of warrants	-42,000 vol	0
Filed 2022-09-26 10:30 Tx date 2022-07-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-225,000 vol	502,204
Filed 2022-09-26 10:29 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-502,204 vol	0
Filed 2022-09-26 10:25 Tx date 2022-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-22,500 vol	0
Filed 2022-09-26 10:24 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-100 vol	0
Filed 2022-09-26 10:05 Tx date 2022-07-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-225,000 vol	502,204
Filed 2022-09-26 10:00 Tx date 2022-09-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 55 - Expiration of warrants	-42,000 vol	0
Filed 2022-09-26 09:58 Tx date 2022-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT (25JULY2022 Warrants) 55 - Expiration of warrants	-502,204 vol	225,000
Filed 2022-09-13 13:50 Tx date 2022-09-13	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$19,999 +30,303 vol $0.66 each	30,303
Filed 2022-09-13 13:43 Tx date 2022-08-29	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-09-13 13:41 Tx date 2022-09-13	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+500,000 vol	500,000
Filed 2022-09-13 13:39 Tx date 2022-08-29	$VPH VALEO PHARMA INC.	Steiger, Kyle 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-06-27 16:25 Tx date 2022-06-23	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$9,600 +16,000 vol $0.60 each	170,745
Filed 2022-06-22 09:25 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$7,750 +15,500 vol $0.50 each	8,679,465
Filed 2022-06-22 09:19 Tx date 2022-06-20	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$29,071 +49,500 vol $0.59 each	11,797,884
Filed 2022-06-22 09:18 Tx date 2022-06-20	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$28,999 +50,000 vol $0.58 each	11,748,384
Filed 2022-06-22 09:16 Tx date 2022-06-20	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$29,071 +49,500 vol $0.59 each	9,094,465
Filed 2022-06-22 09:15 Tx date 2022-06-20	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$28,999 +50,000 vol $0.58 each	9,044,965
Filed 2022-06-22 08:47 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,950 +50,000 vol $0.62 each	9,194,465
Filed 2022-06-22 08:47 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,900 +50,000 vol $0.62 each	9,144,465
Filed 2022-06-22 08:46 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,900 +50,000 vol $0.62 each	9,094,465
Filed 2022-06-22 08:46 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,500 +50,000 vol $0.61 each	9,044,465
Filed 2022-06-22 08:45 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,950 +50,000 vol $0.62 each	11,898,384
Filed 2022-06-22 08:44 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,900 +50,000 vol $0.62 each	11,848,384
Filed 2022-06-22 08:44 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,900 +50,000 vol $0.62 each	11,798,384
Filed 2022-06-22 08:44 Tx date 2022-06-21	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,500 +50,000 vol $0.61 each	11,748,384
Filed 2022-06-17 12:45 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$7,500 +15,000 vol $0.50 each
Filed 2022-06-20 17:29 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$28,000 +50,000 vol $0.56 each	8,994,465
Filed 2022-06-20 17:28 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$21,450 +39,000 vol $0.55 each	8,944,465
Filed 2022-06-20 17:28 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$13,750 +25,000 vol $0.55 each	8,905,465
Filed 2022-06-20 17:26 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$28,000 +50,000 vol $0.56 each	11,698,384
Filed 2022-06-20 17:25 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$21,450 +39,000 vol $0.55 each	11,648,384
Filed 2022-06-20 17:25 Tx date 2022-06-17	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$14,000 +25,000 vol $0.56 each	11,609,384
Filed 2022-06-17 12:50 Tx date 2022-06-16	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$26,465 +50,000 vol $0.53 each	8,853,965
Filed 2022-06-17 12:48 Tx date 2022-06-16	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$14,378 +26,500 vol $0.54 each	8,880,465
Filed 2022-06-17 12:48 Tx date 2022-06-16	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$27,130 +50,000 vol $0.54 each
Filed 2022-06-17 12:47 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$13,500 +25,000 vol $0.54 each	8,803,965
Filed 2022-06-17 12:46 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$26,395 +50,000 vol $0.53 each	8,778,965
Filed 2022-06-17 12:45 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$24,790 +50,000 vol $0.4958 each	8,728,965
Filed 2022-06-17 12:45 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$7,500 +15,000 vol $0.50 each	8,678,965
Filed 2022-06-17 12:41 Tx date 2022-06-16	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$14,378 +26,500 vol $0.54 each	11,584,384
Filed 2022-06-17 12:40 Tx date 2022-06-16	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$26,465 +50,000 vol $0.53 each	11,557,884
Filed 2022-06-17 12:39 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$13,500 +25,000 vol $0.54 each	11,507,884
Filed 2022-06-17 12:39 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$26,395 +50,000 vol $0.53 each	11,482,884
Filed 2022-06-17 12:38 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$24,790 +50,000 vol $0.4958 each	11,432,884
Filed 2022-06-17 12:37 Tx date 2022-06-15	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$7,750 +15,500 vol $0.50 each	11,382,884
Filed 2022-05-02 14:02 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$19,999 +37,037 vol $0.54 each	37,037
Filed 2022-05-02 14:01 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$19,999 +37,037 vol $0.54 each	37,037
Filed 2022-05-02 14:00 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$15,000 +27,778 vol $0.54 each	27,778
Filed 2022-05-02 13:59 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$15,000 +27,778 vol $0.54 each	27,778
Filed 2022-05-02 13:57 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$24,999 +46,296 vol $0.54 each	46,296
Filed 2022-05-02 13:27 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$16,500 +25,000 vol $0.66 each	125,000
Filed 2022-05-02 13:02 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		100,000
Filed 2022-05-02 13:01 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$8,100 +15,000 vol $0.54 each	15,000
Filed 2022-05-02 13:01 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$8,100 +15,000 vol $0.54 each
Filed 2022-05-02 13:01 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 13:00 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	150,000
Filed 2022-05-02 13:00 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Léger, Marc François 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 12:17 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	200,000
Filed 2022-05-02 12:16 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Brien, Michelle 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	165,000
Filed 2022-05-02 12:15 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	125,000
Filed 2022-05-02 12:13 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	347,222
Filed 2022-05-02 12:12 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	175,000
Filed 2022-05-02 12:11 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	2,050,000
Filed 2022-05-02 11:55 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$10,800 +20,000 vol $0.54 each	20,000
Filed 2022-05-02 11:55 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$10,800 +20,000 vol $0.54 each
Filed 2022-05-02 11:55 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 11:55 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	215,000
Filed 2022-05-02 11:53 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$10,800 +20,000 vol $0.54 each
Filed 2022-05-02 11:53 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$10,800 +20,000 vol $0.54 each	20,000
Filed 2022-05-02 11:53 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 11:53 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	215,000
Filed 2022-05-02 11:51 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$8,100 +15,000 vol $0.54 each	15,000
Filed 2022-05-02 11:51 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$8,100 +15,000 vol $0.54 each
Filed 2022-05-02 11:51 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 11:50 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Brennan, Maureen 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	215,000
Filed 2022-05-02 11:49 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$13,500 +25,000 vol $0.54 each
Filed 2022-05-02 11:49 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$13,500 +25,000 vol $0.54 each	25,000
Filed 2022-05-02 11:45 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 11:43 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Options 50 - Grant of options	+15,000 vol	15,000
Filed 2022-05-02 11:42 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-30 09:40 Tx date 2022-04-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$24,750 +37,500 vol $0.66 each	1,112,500
Filed 2022-03-09 12:42 Tx date 2022-03-04	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$1,367 +3,419 vol $0.40 each	11,367,384
Filed 2022-03-09 12:40 Tx date 2022-03-04	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$1,040,000 +2,600,000 vol $0.40 each	11,363,965
Filed 2022-03-09 12:38 Tx date 2022-03-04	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 36 - Conversion or exchange	$ -$1,040,000 vol $0.40 each	$0
Filed 2021-12-10 13:09 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 36 - Conversion or exchange	-$50,000 vol	$0
Filed 2021-12-10 13:08 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 36 - Conversion or exchange	-$200,000 vol	$0
Filed 2021-12-10 12:59 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 16 - Acquisition or disposition under a prospectus exemption	+$250,000 vol	$250,000
Filed 2021-12-10 12:58 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 12:54 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 16 - Acquisition or disposition under a prospectus exemption	+$20,000 vol	$20,000
Filed 2021-12-10 12:53 Tx date 2021-06-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 12:51 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 16 - Acquisition or disposition under a prospectus exemption	+$1,540,000 vol	$1,540,000
Filed 2021-12-10 12:50 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 12:35 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 36 - Conversion or exchange	-$1,540,000 vol	$460,000
Filed 2021-12-10 12:34 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 16 - Acquisition or disposition under a prospectus exemption	+$1,540,000 vol	$1,540,000
Filed 2021-12-10 12:27 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures (Non-Convertible) July 2020 36 - Conversion or exchange	-$15,000 vol	$0
Filed 2021-12-10 12:25 Tx date 2021-12-09	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 16 - Acquisition or disposition under a prospectus exemption	+$25,000 vol	$25,000
Filed 2021-12-10 12:24 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 12:02 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024 00 - Opening Balance-Initial SEDI Report
Filed 2021-10-20 15:02 Tx date 2021-10-20	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,663,965
Filed 2021-10-20 15:02 Tx date 2021-10-20	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,613,965
Filed 2021-10-20 14:57 Tx date 2021-10-20	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,763,965
Filed 2021-10-20 14:56 Tx date 2021-10-20	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,713,965
Filed 2021-10-07 13:38 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,563,965
Filed 2021-10-07 13:37 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,513,965
Filed 2021-10-07 13:37 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,463,965
Filed 2021-10-07 13:36 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,413,965
Filed 2021-10-07 13:25 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,663,965
Filed 2021-10-07 13:24 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,613,965
Filed 2021-10-07 13:24 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,563,965
Filed 2021-10-07 13:23 Tx date 2021-10-07	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$45,000 +50,000 vol $0.90 each	8,513,965
Filed 2021-10-05 14:08 Tx date 2021-10-05	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$44,000 +50,000 vol $0.88 each	393,000
Filed 2021-10-05 07:51 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$37,500 +50,000 vol $0.75 each	8,363,965
Filed 2021-10-05 07:50 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$37,500 +50,000 vol $0.75 each	8,313,965
Filed 2021-10-05 07:22 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$37,500 +50,000 vol $0.75 each	8,463,965
Filed 2021-10-05 07:22 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$37,500 +50,000 vol $0.75 each	8,413,965
Filed 2021-10-01 11:24 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	Brien, Michelle 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+150,000 vol	150,000
Filed 2021-10-01 11:23 Tx date 2021-10-01	$VPH VALEO PHARMA INC.	Brien, Michelle 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-10-01 09:29 Tx date 2021-09-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$78,174 +109,000 vol $0.72 each	8,263,965
Filed 2021-09-30 15:29 Tx date 2021-09-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$78,174 +109,000 vol $0.72 each	8,363,965
Filed 2021-09-29 17:25 Tx date 2021-09-28	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$14,820 +19,000 vol $0.78 each	154,745
Filed 2021-09-27 13:24 Tx date 2021-09-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$32,908 +43,300 vol $0.76 each	1,377,150
Filed 2021-07-23 07:38 Tx date 2021-07-22	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$40,500 +67,500 vol $0.60 each	1,898,055
Filed 2021-07-16 07:45 Tx date 2021-07-15	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$100,005 +150,000 vol $0.67 each	1,830,555
Filed 2021-06-29 17:25 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Warrants (29JUNE2024, $1.25) 15 - Acquisition or disposition under a prospectus	+200,000 vol	200,000
Filed 2021-06-29 17:23 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Warrants (29JUNE2024, $1.25) 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-29 17:22 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$200,000 +200,000 vol $1.00 each	343,000
Filed 2021-06-29 15:07 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Warrants (29JUNE2024, $1.25) 15 - Acquisition or disposition under a prospectus	+25,000 vol	25,000
Filed 2021-06-29 15:06 Tx date 2021-01-18	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Warrants (29JUNE2024, $1.25) 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-29 15:06 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$25,000 +25,000 vol $1.00 each	199,300
Filed 2021-06-29 15:02 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (29JUNE2024, $1.25) 15 - Acquisition or disposition under a prospectus	+100,000 vol	100,000
Filed 2021-06-29 15:01 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (29JUNE2024, $1.25) 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-29 15:00 Tx date 2021-06-29	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$100,000 +100,000 vol $1.00 each	8,254,965
Filed 2021-06-17 09:59 Tx date 2021-06-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+150,000 vol	150,000
Filed 2021-06-17 09:58 Tx date 2021-06-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-17 09:57 Tx date 2021-06-15	$VPH VALEO PHARMA INC.	Komari, Nelly 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-26 08:46 Tx date 2021-05-25	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$28,000 +25,000 vol $1.12 each	25,000
Filed 2021-05-26 08:45 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-26 08:43 Tx date 2021-05-25	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$56,000 +50,000 vol $1.12 each	50,000
Filed 2021-05-26 08:41 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-26 08:39 Tx date 2021-05-25	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 56 - Grant of rights	$448,000 +400,000 vol $1.12 each	400,000
Filed 2021-05-26 08:38 Tx date 2021-01-18	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-26 08:38 Tx date 2021-05-25	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	2,000,000
Filed 2021-05-07 09:35 Tx date 2021-05-07	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$626.58 +531 vol $1.18 each	390,000
Filed 2021-05-07 09:19 Tx date 2021-05-04	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,180 +1,000 vol $1.18 each	389,469
Filed 2021-05-07 09:18 Tx date 2021-05-04	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,770 +1,500 vol $1.18 each	6,500
Filed 2021-05-07 09:17 Tx date 2021-05-04	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,770 +1,500 vol $1.18 each
Filed 2021-05-07 09:16 Tx date 2021-05-03	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$2,925 +2,500 vol $1.17 each	388,469
Filed 2021-04-27 16:31 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 16 - Acquisition or disposition under a prospectus exemption	$64,000 +40,000 vol $1.60 each	40,000
Filed 2021-04-27 16:30 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-27 16:29 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 16 - Acquisition or disposition under a prospectus exemption	+$200,000 vol	$200,000
Filed 2021-04-27 16:27 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-27 16:02 Tx date 2021-04-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 51 - Exercise of options	$3,537 +22,110 vol $0.16 each	1,333,850
Filed 2021-04-27 16:01 Tx date 2021-04-27	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-22,110 vol	100,000
Filed 2021-04-27 16:00 Tx date 2021-04-23	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 51 - Exercise of options	$38,992 +243,700 vol $0.16 each	1,311,740
Filed 2021-04-27 15:59 Tx date 2021-04-23	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-243,700 vol	122,110
Filed 2021-04-27 15:57 Tx date 2021-04-20	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 40 - Short sale	$-18,279.90 -17,100 vol $1.07 each	1,068,040
Filed 2021-04-27 15:56 Tx date 2021-04-19	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 40 - Short sale	$-5,450 -5,000 vol $1.09 each	1,085,140
Filed 2021-04-27 15:55 Tx date 2021-04-16	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 40 - Short sale	$-11.50 -10 vol $1.15 each	990,140
Filed 2021-04-27 15:02 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 16 - Acquisition or disposition under a prospectus exemption	$32,000 +20,000 vol $1.60 each	20,000
Filed 2021-04-27 15:01 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-27 15:01 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 16 - Acquisition or disposition under a prospectus exemption	$ +$100,000 vol $100,000 each	$100,000
Filed 2021-04-27 15:00 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-27 14:54 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 16 - Acquisition or disposition under a prospectus exemption	$640,000 +400,000 vol $1.60 each	400,000
Filed 2021-04-27 14:46 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants (26APRIL2023, $1.60) 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-27 12:11 Tx date 2021-04-26	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 16 - Acquisition or disposition under a prospectus exemption	+$2,000,000 vol	$2,000,000
Filed 2021-04-27 12:05 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures Non-Convertible, Unsecured, 8%, 9 months 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-23 13:14 Tx date 2021-04-23	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$5,471 +4,800 vol $1.14 each	143,000
Filed 2021-04-22 06:24 Tx date 2021-04-21	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$10,710 +10,200 vol $1.05 each	138,200
Filed 2021-04-20 10:56 Tx date 2021-04-19	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 51 - Exercise of options	$16,000 +100,000 vol $0.16 each	1,090,150
Filed 2021-04-20 10:55 Tx date 2021-04-19	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-100,000 vol	365,810
Filed 2021-04-20 10:54 Tx date 2021-04-15	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 40 - Short sale	$-113,250 -100,000 vol $1.13 each	990,150
Filed 2021-04-19 07:05 Tx date 2021-04-15	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$175,901 +154,300 vol $1.14 each	174,300
Filed 2021-04-17 11:05 Tx date 2021-04-14	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$5,500 +5,000 vol $1.10 each	385,969
Filed 2021-04-09 10:11 Tx date 2021-04-07	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$23,000 +20,000 vol $1.15 each	20,000
Filed 2021-01-18 15:36 Tx date 2021-01-18	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+1,950,000 vol	1,950,000
Filed 2021-01-18 15:35 Tx date 2021-01-18	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-01-18 15:34 Tx date 2021-01-18	$VPH VALEO PHARMA INC.	Fasano, Frederic 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2020-09-16 12:42 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$100,800 +84,000 vol $1.20 each	8,154,965
Filed 2020-09-16 12:35 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants VPH.WT. A.(10SEP2022 Warrants) 15 - Acquisition or disposition under a prospectus	+42,000 vol	42,000
Filed 2020-09-16 12:35 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants VPH.WT. A.(10SEP2022 Warrants) 00 - Opening Balance-Initial SEDI Report
Filed 2020-09-16 12:34 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$100,800 +84,000 vol $1.20 each	8,154,965
Filed 2020-09-16 12:27 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 15 - Acquisition or disposition under a prospectus	+42,000 vol	42,000
Filed 2020-09-16 12:25 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 15 - Acquisition or disposition under a prospectus	+42,000 vol
Filed 2020-09-16 12:23 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 00 - Opening Balance-Initial SEDI Report
Filed 2020-09-16 12:22 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$8,467,200,000 +84,000 vol $100,800 each
Filed 2020-09-14 11:19 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 15 - Acquisition or disposition under a prospectus	+12,500 vol	12,500
Filed 2020-09-14 11:12 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants VPH.WT. A.(10SEP2022 Warrants) 00 - Opening Balance-Initial SEDI Report
Filed 2020-09-14 11:12 Tx date 2020-09-10	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$30,000 +25,000 vol $1.20 each	1,680,555
Filed 2020-08-05 10:05 Tx date 2020-08-05	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$28,400 +20,000 vol $1.42 each	135,745
Filed 2020-07-15 10:46 Tx date 2020-07-15	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$12,456 +8,650 vol $1.44 each	1,090,150
Filed 2020-07-14 08:10 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+75,000 vol	275,000
Filed 2020-07-14 08:09 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$50,000 vol	$50,000
Filed 2020-07-14 08:09 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 08:05 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Wells, Michael G. 4 - Director of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+102,000 vol	102,000
Filed 2020-07-14 08:04 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Wells, Michael G. 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 08:03 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Wells, Michael G. 4 - Director of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$68,000 vol	$68,000
Filed 2020-07-14 08:02 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Wells, Michael G. 4 - Director of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 08:01 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+22,500 vol	22,500
Filed 2020-07-14 08:00 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 07:59 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$15,000 vol	$15,000
Filed 2020-07-14 07:59 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 07:43 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+225,000 vol	727,204
Filed 2020-07-14 07:42 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$150,000 vol	$150,000
Filed 2020-07-14 07:41 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 07:39 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+225,000 vol	727,204
Filed 2020-07-14 07:37 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$150,000 vol	$150,000
Filed 2020-07-14 07:36 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-13 15:51 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+82,500 vol	701,000
Filed 2020-07-13 15:49 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$55,000 vol	$55,000
Filed 2020-07-13 15:43 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-13 12:01 Tx date 2020-07-13	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$19,440 +13,500 vol $1.44 each	1,081,500
Filed 2020-07-13 11:55 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 11 - Acquisition or disposition carried out privately	+$17,000 vol	$17,000
Filed 2020-07-13 11:54 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-13 11:49 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures 16 - Acquisition or disposition under a prospectus exemption	+$15,000 vol
Filed 2020-07-13 11:48 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures (Non-Convertible) July 2020 16 - Acquisition or disposition under a prospectus exemption	+$15,000 vol	$15,000
Filed 2020-07-13 11:47 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures (Non-Convertible) July 2020 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-13 11:28 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 53 - Grant of warrants	+25,500 vol	386,015
Filed 2020-07-13 08:57 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures 16 - Acquisition or disposition under a prospectus exemption	+$15,000 vol	$15,000
Filed 2020-07-13 08:57 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures 16 - Acquisition or disposition under a prospectus exemption	+$15,000 vol
Filed 2020-07-13 08:56 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Debentures 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-13 08:43 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+22,500 vol	22,500
Filed 2020-07-13 08:41 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-10 11:15 Tx date 2020-07-10	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$-3,920 -3,500 vol $1.12 each	5,000
Filed 2020-07-03 17:43 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$60,000 +100,000 vol $0.60 each	100,000
Filed 2020-07-03 17:42 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 15:22 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	100,000
Filed 2020-07-02 15:21 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 15:04 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	465,810
Filed 2020-07-02 13:38 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+175,000 vol	175,000
Filed 2020-07-02 13:37 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Therrien, Nathalie 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 13:34 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	100,000
Filed 2020-07-02 13:33 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 09:21 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	322,222
Filed 2020-07-01 16:43 Tx date 2020-06-30	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$60,000 +100,000 vol $0.60 each	1,075,000
Filed 2020-05-25 12:10 Tx date 2020-05-25	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$32,000 +80,000 vol $0.40 each	1,655,555
Filed 2020-05-19 16:41 Tx date 2020-05-14	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$2,250 +25,000 vol $0.09 each	618,500
Filed 2020-05-19 13:19 Tx date 2020-05-14	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$3,400 +40,000 vol $0.085 each	593,500
Filed 2020-02-28 18:07 Tx date 2020-02-27	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 16 - Acquisition or disposition under a prospectus exemption	$ +$154,000 vol $1,000 each	$154,000
Filed 2020-02-28 18:06 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 18:00 Tx date 2020-02-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 16 - Acquisition or disposition under a prospectus exemption	$ +$100,000 vol $1,000 each	$100,000
Filed 2020-02-28 18:00 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 17:57 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 Years 00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 17:54 Tx date 2020-02-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 16 - Acquisition or disposition under a prospectus exemption	$ +$1,040,000 vol $1,000 each	$1,040,000
Filed 2020-02-28 17:53 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 years ($0.40 conversion price) 00 - Opening Balance-Initial SEDI Report
Filed 2020-02-28 17:33 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Convertible Debentures Series 1, 12%, 3 Years 00 - Opening Balance-Initial SEDI Report
Filed 2020-02-26 08:56 Tx date 2020-02-25	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,890 +10,000 vol $0.489 each	1,068,000
Filed 2020-02-21 10:37 Tx date 2020-02-19	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,020 +2,000 vol $0.51 each	2,303,636
Filed 2020-02-21 10:36 Tx date 2020-02-19	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,080 +8,000 vol $0.51 each	2,301,636
Filed 2020-02-21 10:35 Tx date 2020-02-19	$VPH VALEO PHARMA INC.	Léger, Marc François 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,800 +10,000 vol $0.48 each	2,293,636
Filed 2020-02-19 15:02 Tx date 2020-02-19	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$7,440 +16,000 vol $0.465 each	128,000
Filed 2020-02-19 15:01 Tx date 2020-02-18	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$5,580 +12,000 vol $0.465 each	112,000
Filed 2020-02-18 11:11 Tx date 2020-02-18	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$910.00 +2,000 vol $0.455 each	8,500
Filed 2020-02-12 10:50 Tx date 2020-02-12	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,443 +70,000 vol $0.4349 each	1,058,000
Filed 2020-02-12 09:45 Tx date 2020-02-12	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,058 +70,000 vol $0.4294 each
Filed 2020-02-12 09:45 Tx date 2020-02-12	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$30,058 +70,000 vol $0.4294 each	1,058,000
Filed 2020-01-02 16:40 Tx date 2019-12-31	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$8,988 +20,000 vol $0.4494 each	988,000
Filed 2020-01-02 07:59 Tx date 2019-12-31	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$95.00 +1,000 vol $0.095 each	553,500
Filed 2019-12-28 06:55 Tx date 2019-12-24	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$3,820 +8,000 vol $0.4775 each	1,575,555
Filed 2019-12-26 07:47 Tx date 2019-12-23	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,250 +10,000 vol $0.425 each	1,567,555
Filed 2019-12-20 12:26 Tx date 2019-12-19	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,975 +5,000 vol $0.395 each	1,557,555
Filed 2019-12-17 12:51 Tx date 2019-12-17	$VPH VALEO PHARMA INC.	Skinner, Jeffrey Michael 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$9,152 +26,000 vol $0.352 each	968,000
Filed 2019-12-16 17:21 Tx date 2019-12-16	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$3,500 +10,000 vol $0.35 each	1,552,555
Filed 2019-12-13 12:13 Tx date 2019-12-12	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$480.00 +1,500 vol $0.32 each	1,542,555
Filed 2019-12-13 12:12 Tx date 2019-12-11	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,239 +15,000 vol $0.2826 each	1,541,055
Filed 2019-12-09 16:50 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+200,000 vol	200,000
Filed 2019-12-09 16:49 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-09-26 16:27 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 53 - Grant of warrants	+200,000 vol
Filed 2019-12-05 17:10 Tx date 2019-12-05	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$2,925 +10,000 vol $0.2925 each	1,526,055
Filed 2019-12-05 17:09 Tx date 2019-12-04	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,450 +5,000 vol $0.29 each	1,516,055
Filed 2019-12-03 15:32 Tx date 2019-12-02	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$10,000 +200,000 vol $0.05 each	452,500
Filed 2019-12-03 15:31 Tx date 2019-12-03	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$5,000 +100,000 vol $0.05 each	552,500
Filed 2019-12-02 16:14 Tx date 2019-12-02	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$10,000 +200,000 vol $0.05 each
Filed 2019-12-02 16:14 Tx date 2019-12-02	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$10,000 +200,000 vol $0.05 each	452,500
Filed 2019-12-02 14:17 Tx date 2019-11-28	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$17,750 +71,000 vol $0.25 each	1,511,055
Filed 2019-10-23 11:01 Tx date 2019-10-22	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$25,000 +100,000 vol $0.25 each	100,000
Filed 2019-10-23 08:26 Tx date 2019-10-22	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$20,000 +100,000 vol $0.20 each	100,000
Filed 2019-10-23 08:26 Tx date 2019-10-22	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$20,000 +100,000 vol $0.20 each
Filed 2019-10-23 08:25 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Holder: Chantal Bourgoing (Indirect Ownership)	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2019-10-11 14:46 Tx date 2019-10-11	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Common Shares Class A 10 - Acquisition or disposition in the public market	$450.00 +1,500 vol $0.30 each	6,500
Filed 2019-10-01 15:41 Tx date 2019-10-01	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,024 +11,500 vol $0.35 each	1,440,055
Filed 2019-09-27 11:25 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		200,000
Filed 2019-09-27 11:25 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report		200,000
Filed 2019-09-27 07:41 Tx date 2019-09-26	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$312.50 +1,000 vol $0.3125 each	1,428,555
Filed 2019-09-26 16:23 Tx date 2019-09-25	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-09-26 16:18 Tx date 2019-09-25	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2019-09-26 16:27 Tx date 2019-09-24	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 53 - Grant of warrants	+200,000 vol	400,000
Filed 2019-09-26 16:23 Tx date 2019-09-25	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report		200,000
Filed 2019-09-26 16:18 Tx date 2019-09-25	$VPH VALEO PHARMA INC.	Trudeau, Michel Claude 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report		200,000
Filed 2019-09-26 15:44 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: 9294-5351 Québec Inc. (Indirect Ownership)	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2019-09-25 08:51 Tx date 2019-09-19	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$2,800 +56,000 vol $0.05 each	252,500
Filed 2019-09-20 08:00 Tx date 2019-09-19	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$70.00 +1,000 vol $0.07 each	196,500
Filed 2019-09-18 13:38 Tx date 2019-09-18	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$46,398 +148,000 vol $0.3135 each	1,427,555
Filed 2019-09-18 13:37 Tx date 2019-09-17	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$3,624 +12,500 vol $0.29 each	1,279,555
Filed 2019-09-18 13:36 Tx date 2019-09-16	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$11,455 +39,500 vol $0.29 each	1,267,055
Filed 2019-09-18 13:35 Tx date 2019-09-16	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$150.00 +1,500 vol $0.10 each	195,500
Filed 2019-09-12 17:22 Tx date 2019-09-12	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$3,430 +49,000 vol $0.07 each	194,000
Filed 2019-09-12 17:21 Tx date 2019-09-12	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$1,250 +25,000 vol $0.05 each	145,000
Filed 2019-08-30 15:09 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 35 - Stock dividend	-1,253,327 vol	360,515
Filed 2019-08-30 15:01 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Simcor Canada Holdings Inc. (Control or Direction)	Warrants 35 - Stock dividend	+601,354 vol	601,354
Filed 2019-08-30 15:00 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Simcor Canada Holdings Inc. (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-30 14:59 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 35 - Stock dividend	+104,300 vol	104,300
Filed 2019-08-30 14:52 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-29 16:40 Tx date 2019-08-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$6,090 +21,000 vol $0.29 each	1,227,555
Filed 2019-08-29 10:52 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 35 - Stock dividend	$6.50 +100 vol $0.065 each	100
Filed 2019-08-29 10:42 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 35 - Stock dividend	+100 vol
Filed 2019-08-29 10:36 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-28 17:27 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Klug Investments Inc (Control or Direction)	Warrants 35 - Stock dividend	$2,139 +32,909 vol $0.065 each	32,909
Filed 2019-08-28 17:25 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Klug Investments Inc (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-28 17:24 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 35 - Stock dividend	$690.63 +10,625 vol $0.065 each	58,428
Filed 2019-08-28 17:19 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Perry, Ronald S. 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Warrants 35 - Stock dividend	$135.40 +2,083 vol $0.065 each	2,083
Filed 2019-08-28 17:16 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Perry, Ronald S. 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-28 17:13 Tx date 2019-08-28	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 35 - Stock dividend	$-81,466.255 -1,253,327 vol $0.065 each	360,515
Filed 2019-08-27 14:17 Tx date 2019-08-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$870.00 +3,000 vol $0.29 each	380,969
Filed 2019-08-27 14:16 Tx date 2019-08-27	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,450 +5,000 vol $0.29 each	377,969
Filed 2019-08-22 11:41 Tx date 2019-08-22	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$3,500 +10,000 vol $0.35 each	1,206,555
Filed 2019-08-21 17:21 Tx date 2019-08-21	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$680.00 +2,000 vol $0.34 each	1,196,555
Filed 2019-08-21 17:20 Tx date 2019-08-21	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$8,250 +25,000 vol $0.33 each	1,194,555
Filed 2019-07-30 12:26 Tx date 2019-07-29	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,600 +4,000 vol $0.40 each	372,969
Filed 2019-07-30 12:25 Tx date 2019-07-29	$VPH VALEO PHARMA INC.	Allard, Guy Paul 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$1,000 +2,500 vol $0.40 each	368,969
Filed 2019-07-29 16:27 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,842 vol	1,613,842
Filed 2019-07-29 16:26 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,921 +1,613,842 vol $0.50 each	21,780,130
Filed 2019-07-29 13:53 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	502,204
Filed 2019-07-29 13:52 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	452,204
Filed 2019-07-29 13:51 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	8,070,965
Filed 2019-07-29 13:51 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	8,020,965
Filed 2019-07-29 13:43 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	8,070,965
Filed 2019-07-29 13:43 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	502,204
Filed 2019-07-29 13:42 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	452,204
Filed 2019-07-29 13:41 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$25,000 +50,000 vol $0.50 each	8,020,965
Filed 2019-07-29 08:06 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,842 vol	1,613,842
Filed 2019-07-29 08:05 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,921 +1,613,842 vol $0.50 each	21,780,130
Filed 2019-07-26 15:41 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,482 vol
Filed 2019-07-26 15:38 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,741 +1,613,482 vol $0.50 each
Filed 2019-07-26 12:14 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,482 vol
Filed 2019-07-26 12:10 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,741 +1,613,482 vol $0.50 each
Filed 2019-07-26 15:41 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,482 vol	1,613,482
Filed 2019-07-26 15:39 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-26 15:38 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Steve 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,741 +1,613,482 vol $0.50 each	21,779,770
Filed 2019-07-26 14:44 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Simcor Canada Holdings Inc. 3 - 10% Security Holder of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,482 vol	1,613,482
Filed 2019-07-26 14:42 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Simcor Canada Holdings Inc. 3 - 10% Security Holder of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-26 14:41 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Simcor Canada Holdings Inc. 3 - 10% Security Holder of Issuer Holder: Manitex Capital Inc. (Control or Direction)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,741 +1,613,482 vol $0.50 each	23,008,517
Filed 2019-07-26 12:21 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+47,803 vol	47,803
Filed 2019-07-26 12:20 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-26 12:19 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Saviuk, Helen 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$23,901 +47,803 vol $0.50 each	2,535,415
Filed 2019-07-26 12:14 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	+1,613,482 vol	1,613,482
Filed 2019-07-26 12:12 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-26 12:10 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Manitex Capital Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$806,741 +1,613,482 vol $0.50 each	21,779,770
Filed 2019-07-25 14:47 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 15 - Acquisition or disposition under a prospectus	$60,000 +120,000 vol $0.50 each	120,000
Filed 2019-07-25 14:45 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-25 14:44 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$60,000 +120,000 vol $0.50 each	1,169,555
Filed 2019-07-25 14:22 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 16 - Acquisition or disposition under a prospectus exemption	$51,102 +102,204 vol $0.50 each	402,204
Filed 2019-07-25 14:21 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 15 - Acquisition or disposition under a prospectus	$150,000 +300,000 vol $0.50 each	300,000
Filed 2019-07-25 14:20 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-25 14:18 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$51,102 +102,204 vol $0.50 each	7,970,965
Filed 2019-07-25 14:17 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$150,000 +300,000 vol $0.50 each	7,868,761
Filed 2019-07-25 14:14 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	$51,102 +102,204 vol $0.50 each	402,204
Filed 2019-07-25 14:13 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 15 - Acquisition or disposition under a prospectus	$150,000 +300,000 vol $0.50 each	300,000
Filed 2019-07-25 14:10 Tx date 2018-12-27	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-25 14:01 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 16 - Acquisition or disposition under a prospectus exemption	$51,102 +102,204 vol $0.50 each	7,970,965
Filed 2019-07-25 14:00 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 15 - Acquisition or disposition under a prospectus	$150,000 +300,000 vol $0.50 each	7,868,761
Filed 2019-07-25 11:29 Tx date 2019-07-25	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$3,000 +7,500 vol $0.40 each	1,049,555
Filed 2019-07-25 11:28 Tx date 2019-07-24	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$4,950 +11,000 vol $0.45 each	1,042,055
Filed 2019-07-25 11:27 Tx date 2019-07-24	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$460.00 +1,000 vol $0.46 each	1,031,055
Filed 2019-03-22 Tx date 2019-03-20	$VPH VALEO PHARMA INC.	MacKay, Richard J. 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: 100079 Canada Inc. (Indirect Ownership)	Common Shares Class A 36 - Conversion or exchange	$22,326 +55,815 vol $0.40 each	7,568,761
Filed 2019-03-22 Tx date 2019-03-20	$VPH VALEO PHARMA INC.	100079 Canada Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$22,326 +55,815 vol $0.40 each	7,568,761
Filed 2019-03-22 Tx date 2019-03-20	$VPH VALEO PHARMA INC.	Hogue, Vincent 4 - Director of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$962.40 +2,406 vol $0.40 each	252,406
Filed 2019-03-20 Tx date 2019-03-20	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 36 - Conversion or exchange	$22.00 +55 vol $0.40 each	1,030,055
Filed 2019-03-05 Tx date 2019-03-01	$VPH VALEO PHARMA INC.	Mainville, Luc 5 - Senior Officer of Issuer Direct Ownership	Common Shares Class A 10 - Acquisition or disposition in the public market	$700.00 +1,000 vol $0.70 each	1,030,000